Provided by Tiger Fintech (Singapore) Pte. Ltd.

Dr Reddy's Laboratories

12.71
+0.01000.08%
Post-market: 12.65-0.0643-0.51%19:50 EDT
Volume:1.41M
Turnover:17.90M
Market Cap:10.59B
PE:16.90
High:12.80
Open:12.68
Low:12.65
Close:12.70
Loading ...

Dr. Reddy’s Laboratories Limited (RDY): Among the Best Indian Stocks for the Next 10 Years

Insider Monkey
·
09 Oct 2024

Don't Avoid Quality 'Growth'

LiveWire
·
09 Oct 2024

Aurigene Oncology Limited Announces Promising Results of Phase 1 Study for India’s First Trial for Novel Autologous CAR-T Cell Therapy for Multiple Myeloma

Business Wire
·
08 Oct 2024

Dr. Reddy’s Unveils New Danish Subsidiary

TipRanks
·
08 Oct 2024

Dr. Reddy’s Announces Share Subdivision Date

TIPRANKS
·
05 Oct 2024

Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Friday Trading

MT Newswires Live
·
04 Oct 2024

Dr. Reddy’s signs voluntary licensing agreement with Gilead Sciences to manufacture and commercialise Lenacapavir in India and other countries

Business Wire
·
02 Oct 2024

Dr. Reddy’s Expands Access to HIV Treatment

TIPRANKS
·
02 Oct 2024

Gilead Sciences Signs Licensing Deals With 6 Drugmakers to Manufacture HIV Prevention Drug Lenacapavir

MT Newswires Live
·
02 Oct 2024

Dr. Reddy’s Subsidiary Chirotech Dissolved

TIPRANKS
·
02 Oct 2024

Dr. Reddy’s Acquires Global NRT Leader Nicotinell

TIPRANKS
·
30 Sep 2024

Dr. Reddy’s Expands Portfolio with $620M Investment

TIPRANKS
·
28 Sep 2024

Asian Equities Traded in the US as American Depositary Receipts Decline in Friday Trading

MT Newswires Live
·
27 Sep 2024

Asian Equities Traded in the US as American Depositary Receipts Drop in Wednesday Trading

MT Newswires Live
·
25 Sep 2024

Dr. Reddy’s Set to Discuss Upcoming Financial Results

TIPRANKS
·
24 Sep 2024

Asian Equities Traded in the US as American Depositary Receipts Advance in Monday Trading

MT Newswires Live
·
23 Sep 2024